A case with multiple gynecological malignancies

International Journal of Gynecological Cancer

Volumn 15, Issue 2, 2005, Pages 372-376

  Goker, B O ^a,c   Bese, T ^b   Ilvan, S ^a   Yilmaz, E ^a   Demirkiran, F ^b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c NONE   (Turkey)

Author keywords

Gynecological tumor; Multiprimary; Postradiational sarcoma

Indexed keywords

CYCLOPHOSPHAMIDE; DACTINOMYCIN; EPIRUBICIN; HLA A2 ANTIGEN; HLA A3 ANTIGEN; HLA B ANTIGEN; HLA B35 ANTIGEN; HLA B4 ANTIGEN; HLA B57 ANTIGEN; HLA B6 ANTIGEN; HLA DQ ANTIGEN; HLA DQ6(1) ANTIGEN; HLA DQ7(3) ANTIGEN; HLA DR ANTIGEN; HLA DR1 ANTIGEN; HLA DR3 ANTIGEN; HLA DR51 ANTIGEN; HLA DR52 ANTIGEN; IMMUNOGLOBULIN G; UNCLASSIFIED DRUG; VINCRISTINE; VIRUS CAPSID ANTIGEN;

ADULT; ANALYTIC METHOD; ARTICLE; BLOOD CELL COUNT; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER INVASION; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CASE REPORT; CAUSE OF DEATH; ENDOMETRIUM CARCINOMA; EPSTEIN BARR VIRUS; FEMALE; GYNECOLOGIC CANCER; HEPATITIS B; HEPATITIS B VIRUS; HERPES SIMPLEX VIRUS; HLA SYSTEM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOPATHOLOGY; LYMPHOCYTE SUBPOPULATION; LYMPHOCYTOPENIA; LYMPHOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RADIATION CARCINOGENESIS; SARCOMA; SEROLOGY; SQUAMOUS CELL CARCINOMA; T LYMPHOCYTE; UTERINE CERVIX CANCER; VAGINA CANCER; VIRUS INFECTION; VIRUS ONCOGENE; WART VIRUS;

ADENOCARCINOMA; ENDOMETRIAL NEOPLASMS; EPSTEIN-BARR VIRUS INFECTIONS; FATAL OUTCOME; FEMALE; HUMANS; LYMPHOMA, NON-HODGKIN; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; PALLIATIVE CARE; PAPILLOMAVIRUS INFECTIONS; SARCOMA; UTERINE CERVICAL NEOPLASMS; VAGINAL NEOPLASMS;

EID: 15444364184     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2005.15232.x     Document Type: Article

References (19)

1. Rosenberg SA, Diamond HD, Carver LF. Lymphosarcoma: a review of 1269 cases. Medicine 1964;43:31.
2. Carr I, Hill AS, Hancock B, Neal FE. Malignant lymphoma of the cervix uteri; histology and ultrastructure. J Clin Pathol 1976;29:280.
3. Sun M, Cao J, Zhang G. Ten-case on primary cervical lymphoma [abstract]. Zhonghua Zhong Liu Za Zhi 1997;19:206. Abstract no.10920398.
4. Rose PG, Fraire AE. Multiple primary gynecologic neoplasms in a young HIV-positive patient. J Surg Oncol 1993;53:269-72.
5. Muntz HG, Ferry JA, Flynn D, Fuller AF, Tarazza AA. Stage IE primary malignant lymphomas of the uterine cervix. Cancer 1991;68:2023-32.
6. Awwad JT, Khalil AM, Shamseddine AI, Mufarrij AA. Primary malignant lymphoma of the uterine cervix: is radiotherapy the best therapeutic choice for stage IE. Gynecol Oncol 1994;523:91-3.
7. Nakanishi H, Tomita Y, Myoui A et al. Mutation of the p53 gene in postradiation sarcoma. Lab Invest 1998;78:727-33.
8. Kapp DS, Fischer D, Grady KJ, Schwartz PE. Subsequent malignancies associated with carcinoma of the uterine cervix: including an analysis of the effect of patient and treatment parameters on incidence and sites of metachronous malignancies. Int J Radiat Oncol Biol Phys 1982;8:197-205.
9. McCreddie MRE, MacFarlane GJ, Coates MS, Osborn RA. Risk of second malignant neoplasms following female genital tract cancers in New South Wales (Australia), 1972-91. Int J Gynecol Cancer 1996;6:362-8.
10. Senkus E, Konefka T, Nowaczyk M, Jassem J Second lower genital tract squamous cell carcinoma following cervical cancer. Acta Obstet Gynecol Scand 2000;79:165-70.
11. Pride GL, Buchler DA. Carcinoma of vagina 10 or more years following pelvic irradiation therapy. Am J Obstet Gynecol 1976;127:513-7.
12. Amendola BE, Amendola MA, McClatchey KD, Miller CH. Radiation associated sarcoma: a review of 23 patients with postradiation sarcoma over a 50-year period. Am J Clin Oncol 1989;12:411-5.
13. Mark RJ, Poen J, Tran LM, Fu YS, Heaps J, Parker RG. Post-irradiation sarcoma of the gynecologic tract. A report of 13 cases and discussion of risk of radiation induced gynecologic malignancies. Am J Clin Oncol 1996;19:59-64.
14. 53 gene mutations in human sarcomas. Eur J Cancer 1995;31:735-8.
15. 53 mutation type for soft tissue sarcoma patients. Cancer Res 1996;56:4134-6.
16. Purtilo DT, Manolov G, Manolova Y, Harada S, Lipscomb H. Squamous-cell carcinoma, Kaposi's sarcoma and Burkitt's lymphoma are consequences of impaired immune surveillance of ubiquitous viruses in acquired immune deficiency syndrome, allograft recipients and tropical African patients. IARC Sci Publ 1984;63:749-70.
17. Caruso C, Candore G, Colucci AT. HLA-B8, DR3 phenotype and the antibody response against Epstein-Barr virus. Immunol Invest 1993;22:41-51.
18. Cohen JHM, Vischer TL, Carquin J, Blancard F, Fliedner VE, Jeanett M. HLA-DR antigens and the antibody response against Epstein-Barr virus. Tissue Antigens 1984;23:156-62.
19. Kotsakis A, Sarra E, Peraki M et al. Docetaxel-induced lymphopenia in patients with solid tumors: a prospective phenotypic analysis. Cancer 2000;89:1380-6.